5.alpha.-reductase inhibitors
US5622962A · kind A · utility
1Cited by
9References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 1995 |
| Grant date | Apr 22, 1997 |
| Priority date | — |
| Expiry date | May 11, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A series of benzoquinolin-3-ones are pharmaceuticals effective in treating conditions consequent on both Type I and Type II 5.alpha.-reductase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.